According to Karyopharm Therapeutics 's latest financial reports the company's current earnings are S$0.14 Billion. In 2023 the company made an earning of -S$0.17 Billion, an increase over its 2022 earnings that were of -S$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -S$71.21 Million | -55.88% |
2023 | -S$0.17 Billion | -14.99% |
2022 | -S$0.19 Billion | 43.11% |
2021 | -S$0.14 Billion | -42.09% |
2020 | -S$0.23 Billion | -8.07% |
2019 | -S$0.25 Billion | 5.76% |
2018 | -S$0.24 Billion | 33.02% |
2017 | -S$0.18 Billion | 19.28% |
2016 | -S$0.15 Billion | -7.4% |
2015 | -S$0.17 Billion | 55.96% |
2014 | -S$0.11 Billion | 123.21% |
2013 | -S$46.06 Million |